Statins, skeletal muscle, and ryanodine receptor activation: resolving a 30-year mystery behind statin myotoxicity

Gaetano Santulli

Open source

DOI
10.1186/s40842-025-00267-z
Published
2025-12-23
Container
Cardiovascular Diabetology – Endocrinology Reports
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s40842-025-00267-z,
  title = {Statins, skeletal muscle, and ryanodine receptor activation: resolving a 30-year mystery behind statin myotoxicity},
  author = {Gaetano Santulli},
  year = {2025},
  journal = {Cardiovascular Diabetology – Endocrinology Reports},
  doi = {10.1186/s40842-025-00267-z},
  url = {https://doi.org/10.1186/s40842-025-00267-z}
}

RIS

TY  - JOUR
TI  - Statins, skeletal muscle, and ryanodine receptor activation: resolving a 30-year mystery behind statin myotoxicity
AU  - Gaetano Santulli
PY  - 2025
JO  - Cardiovascular Diabetology – Endocrinology Reports
DO  - 10.1186/s40842-025-00267-z
UR  - https://doi.org/10.1186/s40842-025-00267-z
ER  - 

APA

Santulli, G. (2025). Statins, skeletal muscle, and ryanodine receptor activation: resolving a 30-year mystery behind statin myotoxicity. Cardiovascular Diabetology – Endocrinology Reports. https://doi.org/10.1186/s40842-025-00267-z

Source records